$75.46
1.021.37%
近くで: Nov 19, 4:00 PM EST

CareDx (CDNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $0.70 | $0.22 | 218.2 % |
| Q2 | Jul 30, 2026 | $0.37 | $0.20 | 85.0 % |
| Q1 | Apr 28, 2026 | $0.34 | $0.08 | 325.0 % |
| Q4 | Feb 24, 2026 | $0.12 | $0.23 | -47.8 % |
Quarterly Revenue (Billions)
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $139.36M | $122.04M | 14.2 % |
| Q2 | Jul 30, 2026 | $131.95M | $114.11M | 15.6 % |
| Q1 | Apr 28, 2026 | $117.70M | $105.50M | 11.6 % |
| Q4 | Feb 24, 2026 | $108.39M | $102.68M | 5.56 % |
CareDx (CDNA) は、10 29, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$520M - $530Mの範囲と予想しています。
以前のガイダンスと比較して、CareDxは売上高予測を以前の範囲である引き上げから$490M - $500Mに引き上げました。
CareDxは、27から1 9, 2023の間に10 29, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 14 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.22 | $0.20 | $0.08 | $0.23 |
| Actual | $0.70 | $0.37 | $0.34 | $0.12 |
| Surprise | +218.2% | +85.0% | +325.0% | -47.8% |
| Revenue | ||||
| Estimate | $122.0M | $114.1M | $105.5M | $102.7M |
| Actual | $139.4M | $131.9M | $117.7M | $108.4M |
| Surprise | +14.2% | +15.6% | +11.6% | +5.56% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.32 | $0.27 | $0.19 | $0.25 |
| Revenue | ||||
| Consensus | $135.8M | $131.0M | — | — |